About: Benefits of complementary therapy with insulin aspart versus human regular insulin in persons with type 2 diabetes mellitus

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Benefits of complementary therapy with insulin aspart versus human regular insulin in persons with type 2 diabetes mellitus Goto Sponge NotDistinct Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

Attributes	Values
rdf:type	skos:Concept http://linked.opendata.cz/ontology/domain/vavai/Vysledek
Description	Absorption rates of the phosphate-buffered insulin analogs aspart, lispro, and glulisine prevail over that of regular human insulin. The aim of this prospective observational open-label controlled study was to compare the effects of aspart and human regular insulin resulting from their sequential long-lasting routine administration in small preprandial boluses to individuals with type 2 diabetes acccording to identical algorithms Absorption rates of the phosphate-buffered insulin analogs aspart, lispro, and glulisine prevail over that of regular human insulin. The aim of this prospective observational open-label controlled study was to compare the effects of aspart and human regular insulin resulting from their sequential long-lasting routine administration in small preprandial boluses to individuals with type 2 diabetes acccording to identical algorithms (en) Cíl: Cílem této prospektivní observační otevřené studie bylo porovnat účinky inzulínem Aspart s účinky krátkodobého humánního inzulínu při dlouhodobém podávání v malých prepondiálních dávkách osobám s diabetem 2. typu na základě stejných algoritmů. Metoda: Bylo vyšetřeno 57 osob s DM 2. typu (cs)
Title	Benefits of complementary therapy with insulin aspart versus human regular insulin in persons with type 2 diabetes mellitus Benefits of complementary therapy with insulin aspart versus human regular insulin in persons with type 2 diabetes mellitus (en) Výhody komplementární léčby inzulin aspartátem versus normálním lidským inzulinem u nemocných s diabetem II. typu (cs)
skos:prefLabel	Benefits of complementary therapy with insulin aspart versus human regular insulin in persons with type 2 diabetes mellitus Benefits of complementary therapy with insulin aspart versus human regular insulin in persons with type 2 diabetes mellitus (en) Výhody komplementární léčby inzulin aspartátem versus normálním lidským inzulinem u nemocných s diabetem II. typu (cs)
skos:notation	RIV/00216208:11120/07:00001307!RIV09-MZ0-11120___
http://linked.open...avai/riv/aktivita	P Z
http://linked.open...avai/riv/aktivity	P(NR7825), Z(MZ00000064211)
http://linked.open...iv/cisloPeriodika	3
http://linked.open...vai/riv/dodaniDat	2009
http://linked.open...aciTvurceVysledku	Zatloukal, Petr
http://linked.open.../riv/druhVysledku	J - Článek v odborném periodiku
http://linked.open...iv/duvernostUdaju	S - Úplné a pravdivé údaje nepodléhající ochraně podle zvláštních právních předpisů
http://linked.open...titaPredkladatele	Univerzita Karlova v Praze / 3. lékařská fakulta
http://linked.open...dnocenehoVysledku	411535
http://linked.open...ai/riv/idVysledku	RIV/00216208:11120/07:00001307
http://linked.open...riv/jazykVysledku	eng - angličtina
http://linked.open.../riv/klicovaSlova	insulin Aspart; complementary insulin therapy; type 2 diabetes mellitus (en)
http://linked.open.../riv/klicoveSlovo	type 2 diabetes mellitus complementary insulin therapy insulin Aspart
http://linked.open...odStatuVydavatele	US - Spojené státy americké
http://linked.open...ontrolniKodProRIV	[93C097BF2967]
http://linked.open...i/riv/nazevZdroje	Diabetes Technology & Therapeutics
http://linked.open...in/vavai/riv/obor	FC
http://linked.open...ichTvurcuVysledku	1 (xsd:int)
http://linked.open...cetTvurcuVysledku	9 (xsd:int)
http://linked.open...vavai/riv/projekt	Determination of glycaemic index of selected foods by healthy persons, type 1 diabetics, type 2 diabetics.
http://linked.open...UplatneniVysledku	2007
http://linked.open...v/svazekPeriodika	9
http://linked.open...iv/tvurceVysledku	Zatloukal, Petr Zapletalová, J. Doubravová, B. Chlupová, L. Malá, E. Pukowietz, L. Chlup, R. Seckar, P. Tancošová, S.
http://linked.open...ain/vavai/riv/wos	000247337800003
http://linked.open...n/vavai/riv/zamer	Diferenciace, apoptosa a regulace transkripce u buněk zhoubných nádorů
issn	1520-9156
number of pages	9 (xsd:int)
http://localhost/t...ganizacniJednotka	11120

Faceted Search & Find service v1.16.118 as of Jun 21 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 75 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software